United States. Securities and Exchange Commission
Actavis and Allergan Shareholder Meetings Set for March 10, 2015
Actavis plc, a specialty pharmaceutical company, and Allergan, Inc., a multi-specialty healthcare company, announced the scheduling of their respective special meetings of shareholders in connection with the pending acquisition of Allergan by Actavis. The meetings are set to take place on March 10, 2015, at 8:30 a.m. local